Selegiline Hydrochloride

盐酸司来吉兰

Report date: 2026/05/17 20:00:15
NME

Base Information

Drug NameSelegiline Hydrochloride
Drug Alias NameSelegilinum hydrochloridum盐酸司立吉林L-Deprenyl hydrochloride丙炔苯丙胺Xilopar +[17] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase B inhibitors
TargetsMonoamine oxidase B
Therapy Area/IndicationsSchizophreniaBorderline Personality DisorderCognition Disorders +[11] 
Global Approved IndicationsParkinson Disease
Approved Indications in ChinaParkinson Disease
Original Approved Country/TerritoryUnited States
Original Approved Date1989/06/05
Country/TerritoryUnited StatesIranMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesCorium Innovations IncChinoin Pharmaceutical And Chemical Works Co LtdSomerset Pharmaceuticals Inc
Inactive CompaniesUniversity Of TabrizQuagen Pharmaceuticals LlcYale University +[8] 
Active IndicationsDepressive Disorder, MajorParkinson Disease
Inactive IndicationsSchizophreniaBorderline Personality DisorderCognition Disorders +[9] 

Other Information

ATC CodeN04BD01
Related LinksWikipediaDrugBankKEGG